# Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes

> **NCT01674985** · PHASE1,PHASE2 · COMPLETED · sponsor: **The Affiliated Hospital of the Chinese Academy of Military Medical Sciences** · enrollment: 43 (actual)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** Microtransplantation

## Key facts

- **NCT ID:** NCT01674985
- **Lead sponsor:** The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-10
- **Final completion:** 2015-12
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2016-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01674985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01674985, "Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01674985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*